Dianthus Therapeutics, Inc. (DNTH)
(Delayed Data from NSDQ)
$25.63 USD
-0.62 (-2.36%)
Updated May 17, 2024 04:00 PM ET
After-Market: $25.52 -0.11 (-0.43%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.49 | 0.00% |
Earnings Summary
For their last quarter, Dianthus Therapeutics, Inc. (DNTH) reported earnings of -$0.54 per share, missing the Zacks Consensus Estimate of -$0.43 per share. This reflects a negative earnings surprise of 25.58%. Look out for DNTH's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.49 per share, reflecting a year-over-year increase of 38.75%.
Earnings History
Price & Consensus
Zacks News for DNTH
Strong Q1 a Boon for the Rest of 2024? 5 Top Growth Picks
DNTH: What are Zacks experts saying now?
Zacks Private Portfolio Services